Independent directory Public ClinicalTrials.gov records United States
ClinicalTrials.gov record
Active, not recruiting Phase 3 Interventional

Fenofibrate for Prevention of DR Worsening

ClinicalTrials.gov ID: NCT04661358

Public ClinicalTrials.gov record NCT04661358. Field values are reproduced from the official study page; the official ClinicalTrials.gov record remains the source of truth for eligibility, enrollment, and contact information.

ClinicalTrials.gov public records Last synced Oct 30, 2026, 12:09 PM EDT

Data is sourced from official ClinicalTrials.gov public API records. Always review the official ClinicalTrials.gov record for the latest information.

Official title

A Randomized Clinical Trial Evaluating Fenofibrate for Prevention of Diabetic Retinopathy Worsening

Brief summary

Reproduced verbatim from the official ClinicalTrials.gov record. Not medical advice.

This randomized trial will evaluate the effect of fenofibrate compared with placebo for prevention of diabetic retinopathy (DR) worsening through 6 years of follow-up in eyes with mild to moderately severe non-proliferative DR (NPDR) and no CI-DME at baseline. In addition to evaluating efficacy, this study aims to evaluate the feasibility of a model for ophthalmologists to prescribe or collaborate with a primary care provider such as an internist/endocrinologist to prescribe and monitor the drug safely. If this study demonstrates that fenofibrate is effective for reducing the onset of proliferative diabetic retinopathy (PDR) or and the results are adopted by the community of retina specialists, a new strategy to prevent vision threatening complications of diabetes could be widely adopted. Widespread use of an oral agent effective at reducing worsening of DR would decrease the numbers of patients who undergo more invasive and much more expensive treatment for DR and who are consequently at risk for side effects that adversely affect visual function. This study will also assess the relationship of glycemic variability, as measured by continuous glucose monitoring with DR outcomes. Ancillary studies will characterize functional and structural outcomes in this cohort.

Study identification

NCT ID
NCT04661358
Recruitment status
Active, not recruiting
Study type
Interventional
Phase
Phase 3
Enrollment
563 participants

Conditions and interventions

Interventions

Drug · Other

Eligibility (public fields only)

Age range
18 Years to 80 Years
Sex
All
Healthy volunteers
Healthy volunteers not accepted

This page does not interpret eligibility. Detailed inclusion and exclusion criteria are on the official ClinicalTrials.gov record.

Study timeline

Start date
Mar 5, 2021 (Actual)
Primary completion
Dec 2029 (Estimated)
Completion
Dec 2029 (Estimated)
Last update posted
Jun 29, 2026

2021 – 2029

United States locations

U.S. sites
66
U.S. states
23
U.S. cities
58
Facility City State ZIP Site status
Kent W. Small, MD, AMC Glendale California 91203-1971 —
Salehi Retina Institute Inc. Huntington Beach California 92647-8693 —
Loma Linda University Loma Linda California 92354 —
UCLA Stein Eye Institute Pasadena California 91103 —
Regents of the University of California, Davis, DBA University of California, Davis Sacramento California 95817 —
The Regents of the University of California, San Francisco San Francisco California 94110 —
National Ophthalmic Research Institute Fort Myers Florida 33912 —
University of Florida- Jacksonville Jacksonville Florida 32209 —
Florida Retina Institute, James A. Staman, MD, PA- Jacksonville Jacksonville Florida 32216 —
Florida Retina Consultants Lakeland Florida 33805 —
Florida Retina Institute, James A. Staman, MD, PA- Orlando Orlando Florida 32806-1101 —
Southeast Eye Institute, P.A. dba Eye Associates of Pinellas Pinellas Park Florida 33782 —
Retina Vitreous Consultants, LLP Sarasota Florida 34233-1261 —
Sarasota Retina Institute Sarasota Florida 34239 —
SEASHORE RETINA LLC DBA Retina Specialists of Tampa Wesley Chapel Florida 33544 —
Southeast Retina Center, P.C. Augusta Georgia 30909 —
Marietta Eye Clinic Marietta Georgia 30060 —
Thomas Eye Group Sandy Springs Georgia 30328 —
Northwestern University Chicago Illinois 60611 —
Rush University Medical Center Chicago Illinois 60612 —
UIC - Dept of Ophthalmology & Visual Sciences Chicago Illinois 60612 —
Illinois Retina Associates SC - Oak Park Site Oak Park Illinois 60304 —
Midwest Eye Institute Indianapolis Indiana 46290 —
John Kenyon American Eye Institute, LLC New Albany Indiana 47150 —
Wolfe Eye Clinic-Cedar Rapids Hiawatha Iowa 52233 —
Wolfe Clinic, P.C.- West Des Moines West Des Moines Iowa 50266-7705 —
Mid-America Retina Consultants, P.A. Overland Park Kansas 66211 —
University of Kansas Medical Center Research Institute, Inc. Prairie Village Kansas 66208 —
Joseph E. Humble and Raymond Haik PTRS DBA Eye Assoc of Northeast Louisiana West Monroe Louisiana 71291-4452 —
Elman Retina Group, P.A. Baltimore Maryland 21237 —
Valley Eye Physicians and Surgeons Ayer Massachusetts 01432 —
Boston Medical Center Corporation Boston Massachusetts 02118 —
Joslin Diabetes Center Boston Massachusetts 02215 —
Henry Ford Health System Detroit Michigan 48202-2689 —
Foundation for Vision Research and Retina Specialists of Michigan, P.C. Grand Rapids Michigan 49546 —
Vitreo-Retinal Associates Grand Rapids Michigan 49546 —
Retina Center, PA DBA Retina Center of Minnesota Minneapolis Minnesota 55404 —
Mayo Clinic Rochester Minnesota 55905 —
The Curators of the University of Missouri Columbia Missouri 65201-5276 —
Washington University Ophthalmology St Louis Missouri 63110 —
Retina Research Institute, LLC St Louis Missouri 63128-1729 —
Retina-Vitreous Surgeons of Central NY, PC Liverpool New York 13088 —
MaculaCare New York New York 10021 —
Retina Associates of Western NY, P.C. Rochester New York 14620-4655 —
Pamela Weber, MD/Island Retina Shirley New York 11967 —
University of North Carolina at Chapel Hill Chapel Hill North Carolina 27517 —
The Cleveland Clinic Foundation DBA Cleveland Clinic Lerner College of Medicine Cleveland Ohio 44120 —
Dean A. McGee Eye Institute Oklahoma City Oklahoma 73104 —
Verum Research LLC Eugene Oregon 97401 —
Oregon Health & Science University Portland Oregon 97239 —
Retina Consultants, LLC Salem Oregon 97302 —
Cascade Medical Research Institute, LLC Springfield Oregon 97477 —
Retina-Vitreous Consultants, Inc. Monroeville Pennsylvania 15146 —
Pittsburg Clinical Trial Consortium Sewickley Pennsylvania 15143 —
Southeastern Retina Associates, P.C. Knoxville Tennessee 37922 —
Vanderbilt Eye Institute Nashville Tennessee 37232 —
Austin Research Center for Retina Austin Texas 78705 —
Austin Retina Associates Austin Texas 78705 —
Retina Consultants of Texas Beaumont Texas 77707 —
Retina Consultants of Texas, PA Bellaire Texas 77401 —
Baylor College of Medicine, Baylor Eye Physicians and Surgeons Houston Texas 77030-4101 —
Texas Retina Associates Lubbock Texas 79424 —
Retinal Consultants of San Antonio San Antonio Texas 78240 —
University of Washington Seattle Washington 98104 —
Gunderson Health System La Crosse Wisconsin 54601 —
Eye Clinic of Wisconsin Wausau Wisconsin 54403 —

Site contact phone numbers, emails, and investigator names are intentionally not displayed here. Open the official ClinicalTrials.gov record for site contact information.

About this trial record page

What this page shows
Public field values for ClinicalTrials.gov record NCT04661358, including study identification, conditions, interventions, eligibility (age, sex, healthy volunteer), timeline, and U.S. site list.
What this page does not do
No medical advice, eligibility judgments, treatment recommendations, study quality scoring, or AI-generated medical summaries. No site contact phone numbers, emails, or investigator names.
Where the data comes from
Sourced from the official ClinicalTrials.gov public API. The official record is the source of truth.
Last refresh
Last update posted Jun 29, 2026 · Synced Oct 30, 2026

Related: full search, browse by condition, browse by drug or therapy, browse by sponsor, browse by U.S. city.

Open the official record

The complete public registry record, listed eligibility criteria, and available contact information for NCT04661358 live on ClinicalTrials.gov.

View official ClinicalTrials.gov record →